Serum Institute of India

Indian biotechnology and biopharmaceuticals company

Serum Institute of India ▸ Facts ▸ Comments ▸ News ▸ Videos

Serum Institute of India (SII) is an Indian biotechnology and biopharmaceuticals company. It is the one of the world's largest vaccine manufacturer. It is located in the city of Pune, Maharashtra, India, and was founded by Cyrus Poonawalla in 1966. The company is a subsidiary of the holding company Poonawalla Investment and Industries.

0 shares	Share Tweet Save Post Send



Novavax vaccine over 90% effective in U.S. trial Novavax Inc on Monday reported late-stage data from its U.S.-based clinical trial showing its vaccine is more than 90% effective against COVID-19 across a variety of variants of the virus. Emer.. Credit: Reuters - Politics Duration: 01:41Published 3 days ago

Lucknow man files complaint against Adar Poonawalla for 'no antibodies' despite jab \| Oneindia News A man in Lucknow has filed a complaint against Serum Institute of India CEO Adar Poonawalla and others, alleging that he did not develop antibodies despite taking a Covishield dose. The complaint has.. Credit: Oneindia Duration: 01:48Published 2 weeks ago

BJP Minister Prakash Javadekar says India will be fully vaccinated by December 2021 \| Oneindia News Union Minister, BJP, Ministry of Environment, Forest and Climate Change, Ministry of Information and Broadcasting, Ministry of Heavy Industries and Public Enterprises, Congress leader, Congress MP,.. Credit: Oneindia Duration: 02:01Published 3 weeks ago

Covid recoveries more than daily active cases \| Highest single-day death: 4,329 \| Oneindia News Serum Institute CEO Adar Poonawalla said that SII has “never exported vaccines at the cost of the people of India"; A vessel with 273 personnel on board, which was stranded near Bombay High during.. Credit: Oneindia Duration: 03:00Published on May 18, 2021

UK agreed to expand partnership on vaccines: MEA Prime Minister Narendra Modi held a virtual summit with his UK counterpart Boris Johnson on May 04. Speaking on the talks between the two leaders, MEA Joint Secretary (Europe West), Sandeep Chakraborty.. Credit: ANI Duration: 01:13Published on May 4, 2021

Watch: Congress responds to Adar Poonawalla’s ‘being threatened’ charge Maharashtra Congress Chief chief Nana Patole has responded to SII chief Adar Poonawalla’s allegation that he is being threatened. Addressing the media, Patole said that Congress is worried over.. Credit: HT Digital Content Duration: 02:05Published on May 3, 2021

Who threatened him?, asks Nana Patole on Adar Poonawalla's threat claims During an interview to a London newspaper, head of Serum Institute of India (SII) Adar Poonawalla, who is one of the vaccine manufacturers in India, revealed that he is receiving threats from big.. Credit: ANI Duration: 01:36Published on May 3, 2021

‘Will return to India in a few days’: Adar Poonawalla after alleged threat calls Serum Institute of India CEO Adar Poonawalla, who has been in the UK on extended stay to evade alleged threats in India over ever-increasing demand for COVID-19 vaccines, has said he will return in a.. Credit: HT Digital Content Duration: 01:50Published on May 2, 2021

‘Getting aggressive calls…’: Adar Poonawalla on Covid vaccine pressure in India Serum Institute of India CEO Adar Poonawalla on Saturday spoke out about the pressures he was under over the production of COVID-19 vaccines to meet the ever-increasing demand in India as the country.. Credit: HT Digital Content Duration: 01:43Published on May 1, 2021

India receives first lot of Sputnik V vaccine India on May 01 got the first lot of Russia's Sputnik V vaccine. The shipment arrived at the Hyderabad airport where Indian authorities received the first batch of 1.5 lakh doses of the Russia-made.. Credit: ANI Duration: 02:00Published on May 1, 2021

Have asked for 67 lakh doses each from both vaccine manufacturing companies: CM Kejriwal Delhi Chief Minister Arvind Kejriwal informed that Delhi government has asked both vaccine manufacturing companies, Bharat Biotech and Serum Institute of India for 67 lakh doses each in next 3 months... Credit: ANI Duration: 01:50Published on April 30, 2021

Phase 3 vaccination drive to delay in Karnataka due to vaccine shortage Karnataka Health Minister K Sudhakar indicated delay in phase 3 of COVID vaccine inoculation, which is supposed to get started from May 01 and also requested people from 18-44 age group to refrain from.. Credit: ANI Duration: 01:38Published on April 30, 2021

Tripura needs 32 lakh vaccine doses for 100% vaccination of people between 18-44 years Tripura's National Health Mission director Dr. Siddharth Shiv Jaiswal informed that the state requires around 32 lakh vaccine doses for 100% vaccination of citizens in the age group of 18 to 44... Credit: ANI Duration: 01:42Published on April 30, 2021

Vaccine manufacturers will supply vaccine by May end: Jharkhand Health Minister Jharkhand Health Minister Banna Gupta on April 29 alleged that vaccine manufacturers said that they can deliver the vaccines only by May end. "We have ordered 25 lakh vaccines each from the Serum.. Credit: ANI Duration: 01:44Published on April 29, 2021

After SII, Bharat Biotech reduces Covaxin price; Rs 400 per dose for state govts Bharat Biotech on Thursday announced a cut in price of its COVID-19 vaccine 'Covaxin' it plans to sell to the states to Rs 400 per dose from the earlier Rs 600. This follows a widespread criticism of.. Credit: HT Digital Content Duration: 01:25Published on April 29, 2021

Adar Poonawalla 'life threat' \| SII CEO gets Y security cover \| Oneindia News Amid threats to his life over Covishield vaccine supplies, the CEO of Serum Institute of India, the world's largest vaccine maker, has got Y category security. The centre granted SII CEO Adar.. Credit: Oneindia Duration: 01:30Published on April 29, 2021

Covid: SII reduces Covishield price, vaccine now at Rs 300 per dose for states Serum Institute of India reduced the vaccine price for the state government from Rs 400 per dose to Rs 300 per dose. SII chairman Adar Poonawalla announced on Twitter a reduction in prices... Credit: HT Digital Content Duration: 01:27Published on April 28, 2021

Rajasthan needs 7 crore doses for 3rd phase of COVID vaccination drive Rajasthan needs 7 crores doses of vaccine, ahead of third phase of COVID vaccination drive, informed state Health Minister Raghu Sharma on April 28. "There are 3.25 cr people in the state b/w 18-45 yrs.. Credit: ANI Duration: 02:07Published on April 28, 2021

You Might Like

SII, Bharat Biotech seek hike in government price for Covid vaccines Serum Institute of India (SII) and Bharat Biotech (BB) are seeking higher prices for Covid-19 vaccines from the Centre amid concerns that the cost of Covishield and Covaxin shots in private hospitals.. IndiaTimes - Published 1 day ago
COVID-19: Serum Institute's Novavax vaccine shows 90% overall efficacy Novavax in collaboration with Indian drug manufacturer Serum Institute of India is manufacturing these vaccines for India and low-income countries. DNA - Published 2 days ago
Covid-19: Novavax set for India launch with Serum Institute of India as manufacturing partner The uncertain path to authorisation in the US for Novavax despite passing the efficacy test with an impressive score of 90.4% might see India emerge as a major destination for the shots with the Serum.. IndiaTimes - Published 2 days ago

Covishield produces more antibodies than Covaxin, finds study Covishield, from the Oxford-AstraZeneca stable, is manufactured by the Serum Institute of India in Pune. Covaxin is the indigenously manufactured vaccine by Hyderabad-based Bharat Biotech in.. IndiaTimes - Published 1 week ago
COVID-19: DCGI approves Serum Institute to manufacture Sputnik V vaccine in India SII has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia for developing Sputnik V. DNA - Published 2 weeks ago
Serum Institute gets DCGI's nod to manufacture Covid jab Sputnik V in India IndiaTimes - Published 2 weeks agoAlso reported by •DNA

Serum Institute of India pushes for indemnity after foreign companies’ request IndiaTimes - Published 2 weeks ago
US to ease Covid vaccine input supply: Kamala Harris to PM Modi US Vice-President Kamala Harris on Thursday spoke to PM Narendra Modi to brief him about the Biden administration’s new vaccine policy that will clear supply chains for AstraZeneca and Novavax.. IndiaTimes - Published 2 weeks ago
Serum Institute seeks indemnity from liability; says 'rules should be same for everyone': Sources IndiaTimes - Published 2 weeks ago
After Pfizer, Serum Institute seeks indemnity over Covid-19 vaccine: Sources Amid discussions over possible legal protection to foreign vaccine manufacturers Pfizer and Moderna over their Covid-19 jabs in India, the Serum Institute of India (SII) has also sought protection.. IndiaTimes - Published 2 weeks ago

HC asks Maharashtra to address security concerns raised by SII CEO IndiaTimes - Published 2 weeks ago
SII unable to supply Covishield vaccine, Maldives looks elsewhere IndiaTimes - Published 2 weeks ago
Covid-19: Government plans 1 crore daily vaccines from middle of July The Centre plans to ramp up vaccination against Covid-19 on a “mission mode”, targeting an average of around 1 crore inoculations per day from around mid-July or August as vaccine supplies are.. IndiaTimes - Published 2 weeks ago	Centre creating 'artificial scarcity' of Covid vaccines to benefit Bharat Biotech, SII: AAP IndiaTimes - Published 3 weeks ago
Serum Institute of India, Bharat Biotech producing minimum 8 crore doses/month, yet only 5 crore will be given by May-end The government in an affidavit in the Supreme Court earlier this month averred that Serum Institute of India (SII) was producing 6.5 crore doses of Covishield a month and Bharat Biotech was producing 2.. IndiaTimes - Published 3 weeks ago	Serum Institute disassociates itself from its executive's remarks on Covid vaccination drive IndiaTimes - Published on May 23, 2021
Never exported vaccines at the cost of people of India: SII Defending its decision to export vaccines, Serum Institute of India (SII) said on Tuesday that it was based on several factors, including the build-up of a large stockpile in January, while cases were.. IndiaTimes - Published on May 19, 2021	Serum Institute CEO Adar Poonawalla finally breaks silence on export of vaccines "Our government extended support wherever possible during this period," Serum Institute said in a statement. DNA - Published on May 18, 2021
WHO reminds Serum Institute of its Covax commitments amidst devastating Covid-19 outbreak, soaring demand in India WHO chief Tedros Adhanom Ghebreyesus has said that once the devastating Covid-19 outbreak in India recedes, the Serum Institute of India will need to "get back on track and catch up" on its delivery.. IndiaTimes - Published on May 18, 2021	No financial aid given to SII & Bharat Biotech: Govt in SC IndiaTimes - Published on May 11, 2021
Govt rejects SII plea to export 50 lakh doses of Covishield to UK Despite the international pressure and several rounds of negotiations by Serum Institute of India (SII), the government has turned down the request from SII to export 50 lakh doses of Covishield to UK.. IndiaTimes - Published on May 10, 2021	At Rs 700-Rs 1,500, price of Covid vaccine in India’s private sector among costliest From Rs 250, the cost of vaccines in the private sector has shot up by up to six times. It now ranges from Rs 700-900 for Covishield manufactured by the Serum Institute of India (SII) and Rs.. IndiaTimes - Published on May 9, 2021
Plea in Bombay HC seeks Z-plus security for SII CEO Adar Poonawalla IndiaTimes - Published on May 6, 2021	Ahead of India-UK summit, Boris Johnson announces 1 billion pound trade deal The UK-India trade deals include an investment of 240 million pounds by the Pune-based Serum Institute of India (SII). DNA - Published on May 4, 2021
Serum, Bharat Biotech got advance of Rs 2,500 crore for 16 crore doses, says government The government on Monday said it had paid an advance of over Rs 2,500 crore to Serum Institute of India and Bharat Biotech for supply of 16 crore doses of Covid vaccine between May and July. While.. IndiaTimes - Published on May 3, 2021	Not possible to ramp up COVID vaccine production overnight: SII CEO Adar Poonawalla Adar Poonawalla issued a statement after some of his comments on vaccine production were misinterpreted. DNA - Published on May 3, 2021Also reported by •IndiaTimes
Media reports alleging Centre hasn't placed any fresh order for Covid-19 vaccines incorrect: Health ministry "The news reports suggest that the last order placed with the two vaccine makers (100 million doses with SII and 20 million doses with Bharat Biotech) was in March 2021. These media reports are.. IndiaTimes - Published on May 3, 2021	Serum Institute of India CEO Adar Poonawalla makes BIG statement over COVID-19 vaccine shortage According to a Financial Times report, SII CEO said that production of vaccines would increase in July from about 60-70 million to 100mln per month. DNA - Published on May 3, 2021
Serum Institute CEO Adar Poonawalla: Will return to India in a few days "Had an excellent meeting with all our partners & stakeholders in the UK. Meanwhile, pleased to state that Covishiled's production is in full swing in Pune. I look forward to reviewing operations upon.. IndiaTimes - Published on May 2, 2021	Serum Institute of India CEO Adar Poonawalla flies to London to after receiving 'threats' from CMs, corporates leaders Poonawalla said that he is planning to stay in the UK for a long time because of constant threats he's getting from CMs and other corporate leaders. DNA - Published on May 2, 2021
Covishield production in full swing, says SII's Adar Poonawalla IndiaTimes - Published on May 2, 2021	Serum Institute plans to start Covid vaccine production outside India: Report The Serum Institute of India, which manufactures the AstraZeneca Covid-19 vaccine, is planning to start vaccine production in other countries as it struggles to meet supply commitments, its chief.. IndiaTimes - Published on May 1, 2021
After SII, Bharat Biotech slashes price of Covaxin for states to Rs 400 Earlier, Bharat Biotech had priced one dose of Covaxin for the state governments at Rs 600 and for private hospitals at Rs 1,200. DNA - Published on April 29, 2021	SII cuts vaccine price for states to Rs 300/dose, terms it a ‘philanthropic gesture’ Facing a public outcry over pricing of Covishield, Serum Institute of India on Wednesday announced a 25% or Rs 100 reduction in its price for state governments, describing it as a “philanthropic.. IndiaTimes - Published on April 28, 2021
Amid threats, Centre provides Y category security to SII CEO Adar Poonawalla Covishield, one of the two COVID-19 vaccines used in India's COVID-19 vaccination drive, is being manufactured by SII. DNA - Published on April 28, 2021	Serum Institute CEO Adar Poonawalla gets 'Y' category security cover IndiaTimes - Published on April 28, 2021
Serum Institute reduces Covishield price for states from Rs 400 to Rs 300 per dose Serum Institute of India on Wednesday announced that it was reducing the price of its Covishield vaccine from Rs 400 to Rs 300 per dose for the states as a "philanthropic gesture". "As a philanthropic.. IndiaTimes - Published on April 28, 2021	SII cuts price of COVID-19 vaccine Covishield for states from Rs 400 to Rs 300 The Serum Institute of India, manufacturer of COVID-19 vaccine Covishield has reduced the price to the states from Rs 400 to Rs 300 per dose. DNA - Published on April 28, 2021
Covid-19: US diverting raw material to Serum Institute for vaccine production The United States on Monday rolled out a series of supportive measures to help India's titanic fight against the Covid-19 upsurge, including diverting raw material to the Serum Institute to India to.. IndiaTimes - Published on April 26, 2021	Govt asks Serum Institute, Bharat Biotech to lower price of Covid-19 vaccines: Official sources The central government on Monday asked the Serum Institute and Bharat Biotech to lower prices of their Covid-19 vaccines amid criticism from various states who objected to profiteering during such a.. IndiaTimes - Published on April 26, 2021
Rs 400 for state, Rs 600 for private: Serum Institute releases rate card of Covishield IndiaTimes - Published on April 21, 2021	Covid-19: Most vaccines may cost 700-1,000 per dose Most companies are expected to price the Covid-19 vaccines around Rs 700-1,000 per dose, when they roll out the jabs in the private market later this year, up from the government-mandated price of Rs.. IndiaTimes - Published on April 20, 2021
Covid-19: White House refuses to comment on lifting ban on vaccine raw materials export to India The White House on Monday did not respond to questions on the request by Serum Institute of India to lift export ban on certain raw materials needed for ramping up production of Covid-19 vaccine. IndiaTimes - Published on April 20, 2021	'India to fund capacity boost at Serum Institute as vaccines run short' IndiaTimes - Published on April 19, 2021
Even as Covid vaccine demand rises, firms may take some weeks to up production Indications are that India’s vaccine production is expected to be limited for a few more weeks though a step-up is expected as Serum Institute of India and Bharat Biotech ramp up capacity, some of.. IndiaTimes - Published on April 9, 2021	Serum Institute asks government for $403 million to boost AstraZeneca vaccine output The Serum Institute of India has asked the government for a grant of 30 billion rupees ($402.97 million) to increase its capacity to make AstraZeneca's Covid-19 vaccine. It is seeking the money to ramp.. IndiaTimes - Published on April 7, 2021
EU seeks 10 million AstraZeneca vaccines from India to meet shortfall: Indian source he European Union has asked India to allow it to buy 10 million doses of AstraZeneca's Covid-19 vaccine from Serum Institute of India, a government official told Reuters, the latest sign of growing.. IndiaTimes - Published on April 1, 2021	India extends shelf life of AstraZeneca vaccine: Report India's drug regulator has allowed the AstraZeneca Covid-19 vaccine to be used for up to nine months from its manufacture date, as opposed to the prescribed six months, according to a document reviewed.. IndiaTimes - Published on March 30, 2021
Covovax trials begin in India, hope to launch it by Sept 2021: Adar Poonawalla Serum Institute of India (SII) CEO Adar Poonawalla on Saturday said clinical trials of Covid-19 vaccine Covovax have begun in India and the company hopes to launch it by September this year. IndiaTimes - Published on March 27, 2021	UK’s vaccination drive hit as Serum Institute ‘delays’ supply The UK’s vaccine rollout “has been hampered” due to the delay in delivery of a promised second batch of five million doses by the Serum Institute of India. A leaked letter, dated March 17, from.. IndiaTimes - Published on March 18, 2021

Serum Institute of India

Indian biotechnology and biopharmaceuticals company

Serum Institute of India ▸ Facts ▸ Comments ▸ News ▸ Videos

You Might Like

SII, Bharat Biotech seek hike in government price for Covid vaccines

COVID-19: Serum Institute's Novavax vaccine shows 90% overall efficacy

Covid-19: Novavax set for India launch with Serum Institute of India as manufacturing partner

Covishield produces more antibodies than Covaxin, finds study

COVID-19: DCGI approves Serum Institute to manufacture Sputnik V vaccine in India

Serum Institute gets DCGI's nod to manufacture Covid jab Sputnik V in India

Serum Institute of India pushes for indemnity after foreign companies’ request

US to ease Covid vaccine input supply: Kamala Harris to PM Modi

Serum Institute seeks indemnity from liability; says 'rules should be same for everyone': Sources

After Pfizer, Serum Institute seeks indemnity over Covid-19 vaccine: Sources

HC asks Maharashtra to address security concerns raised by SII CEO

SII unable to supply Covishield vaccine, Maldives looks elsewhere

Covid-19: Government plans 1 crore daily vaccines from middle of July

Centre creating 'artificial scarcity' of Covid vaccines to benefit Bharat Biotech, SII: AAP

Serum Institute of India, Bharat Biotech producing minimum 8 crore doses/month, yet only 5 crore will be given by May-end

Serum Institute disassociates itself from its executive's remarks on Covid vaccination drive

Never exported vaccines at the cost of people of India: SII

Serum Institute CEO Adar Poonawalla finally breaks silence on export of vaccines

WHO reminds Serum Institute of its Covax commitments amidst devastating Covid-19 outbreak, soaring demand in India

No financial aid given to SII & Bharat Biotech: Govt in SC

Govt rejects SII plea to export 50 lakh doses of Covishield to UK

At Rs 700-Rs 1,500, price of Covid vaccine in India’s private sector among costliest

Plea in Bombay HC seeks Z-plus security for SII CEO Adar Poonawalla

Ahead of India-UK summit, Boris Johnson announces 1 billion pound trade deal

Serum, Bharat Biotech got advance of Rs 2,500 crore for 16 crore doses, says government

Not possible to ramp up COVID vaccine production overnight: SII CEO Adar Poonawalla

Media reports alleging Centre hasn't placed any fresh order for Covid-19 vaccines incorrect: Health ministry

Serum Institute of India CEO Adar Poonawalla makes BIG statement over COVID-19 vaccine shortage

Serum Institute CEO Adar Poonawalla: Will return to India in a few days

Serum Institute of India CEO Adar Poonawalla flies to London to after receiving 'threats' from CMs, corporates leaders

Covishield production in full swing, says SII's Adar Poonawalla

Serum Institute plans to start Covid vaccine production outside India: Report

After SII, Bharat Biotech slashes price of Covaxin for states to Rs 400

SII cuts vaccine price for states to Rs 300/dose, terms it a ‘philanthropic gesture’

Amid threats, Centre provides Y category security to SII CEO Adar Poonawalla

Serum Institute CEO Adar Poonawalla gets 'Y' category security cover

Serum Institute reduces Covishield price for states from Rs 400 to Rs 300 per dose

SII cuts price of COVID-19 vaccine Covishield for states from Rs 400 to Rs 300

Covid-19: US diverting raw material to Serum Institute for vaccine production

Govt asks Serum Institute, Bharat Biotech to lower price of Covid-19 vaccines: Official sources

Rs 400 for state, Rs 600 for private: Serum Institute releases rate card of Covishield

Covid-19: Most vaccines may cost 700-1,000 per dose

Covid-19: White House refuses to comment on lifting ban on vaccine raw materials export to India

'India to fund capacity boost at Serum Institute as vaccines run short'

Even as Covid vaccine demand rises, firms may take some weeks to up production

Serum Institute asks government for $403 million to boost AstraZeneca vaccine output

EU seeks 10 million AstraZeneca vaccines from India to meet shortfall: Indian source

India extends shelf life of AstraZeneca vaccine: Report

Covovax trials begin in India, hope to launch it by Sept 2021: Adar Poonawalla

UK’s vaccination drive hit as Serum Institute ‘delays’ supply